Literature DB >> 26593211

Anti-osteoporosis effect of Epimedium via an estrogen-like mechanism based on a system-level approach.

Feifei Xu1, Yan Ding2, Yingying Guo1, Baoyue Liu1, Zinong Kou3, Wei Xiao4, Jingbo Zhu5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Epimedium is a popular traditional herbal medicine worldwide that has long been used to relieve osteoporosis. The estrogenic properties of the herb are conferred by several phytoestrogens, such as flavonoids, lignans, and steroids. However, the poor understanding on the estrogen-like mechanism of Epimedium at the molecular and system levels limits the applications of this herb in osteoporosis treatment.
MATERIALS AND METHODS: In this study, systems pharmacology was established to investigate the relationship between Epimedium and estrogen against osteoporosis by integrating active component screening, drug-likeness evaluation, herb feature mapping, target prediction and validation, and network analysis.
RESULTS: A total of 77 active components that possessed similar structural features to estrogen as determined using herb feature mapping were selected from Epimedium by oral bioavailability prediction and drug-likeness evaluation. Twenty three osteoporosis-related targets were obtained from the active components of Epimedium as potential targets, 11 of which were common targets with estrogen. All osteoporosis-related targets were further mapped to compound-target and target-pathway networks. Results displayed that Epimedium can exert anti-osteoporosis effects by directly regulating the 11 estrogen-related targets and a set of target proteins on five estrogen-related pathways.
CONCLUSION: This study explained the estrogen-like mechanism of Epimedium in preventing and treating osteoporosis, and provided a new standpoint for exploring the traditional herbal medicine against osteoporosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  (+)-Cycloolivil (PubChem CID: 5316262); (−)-Olivil (PubChem CID: 586733); Apigenin (PubChem CID: 5280443); Astragalin (PubChem CID: 5282102); Baohuoside VI (PubChem CID: 5488005); Baohuoside VII (PubChem CID: 5492427); Epimedin B (PubChem CID: 5748393); Epimedium; Icariin (PubChem CID: 5318997); Icaritin (PubChem CID: 5318980); Osteoporosis; Systems pharmacology; Yinyanghuo C (PubChem CID: 5315395); estrogen-like

Mesh:

Substances:

Year:  2015        PMID: 26593211     DOI: 10.1016/j.jep.2015.11.007

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  17 in total

1.  Study of the osteogenesis effect of icariside II and icaritin on canine bone marrow mesenchymal stem cells.

Authors:  Guangming Luo; Biao Xu; Weihong Wang; Yong Wu; Ming Li
Journal:  J Bone Miner Metab       Date:  2017-12-20       Impact factor: 2.626

2.  Effect of icariin on fracture healing in an ovariectomized rat model of osteoporosis.

Authors:  Hong Cao; Ying Zhang; Wei Qian; Xiao-Peng Guo; Chen Sun; Lei Zhang; Xin-Hua Cheng
Journal:  Exp Ther Med       Date:  2017-03-17       Impact factor: 2.447

3.  Metabolite Profiling, Pharmacokinetics, and In Vitro Glucuronidation of Icaritin in Rats by Ultra-Performance Liquid Chromatography Coupled with Mass Spectrometry.

Authors:  Beibei Zhang; Xiaoli Chen; Rui Zhang; Fangfang Zheng; Shuzhang Du; Xiaojian Zhang
Journal:  J Anal Methods Chem       Date:  2017-07-10       Impact factor: 2.193

4.  Determination of Epimedin B in Rat Plasma and Tissue by LC-MS/MS: Application in Pharmacokinetic and Tissue Distribution Studies.

Authors:  Qianru Feng; Shunjun Xu; Jiejing Yu; Shuai Sun; Liu Yang
Journal:  J Anal Methods Chem       Date:  2017-06-01       Impact factor: 2.193

5.  Epimedium protects steroid-induced avascular necrosis of femoral head in rats by inhibiting autophagy.

Authors:  Su Liu; Yunzong Huang; Chuangli Wang; Shoujing Tian; Youjia Xu; Jianfei Ge
Journal:  Exp Ther Med       Date:  2018-10-03       Impact factor: 2.447

6.  Warm needle acupuncture in primary osteoporosis management: a systematic review and meta-analysis.

Authors:  Ding Luo; Yue Liu; Yanan Wu; Rui Ma; Lin Wang; Ronghe Gu; Wenbin Fu
Journal:  Acupunct Med       Date:  2018-07-09       Impact factor: 2.267

7.  A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency.

Authors:  Huishan Zhao; Yinghua Shan; Zhi Ma; Mingwei Yu; Benjiao Gong
Journal:  Drug Des Devel Ther       Date:  2019-08-22       Impact factor: 4.162

8.  Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Qinming Zhou; Youjie Wang; Jingjing Zhang; Yaping Shao; Song Li; Yuan Wang; Huaibin Cai; Yi Feng; Weidong Le
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

9.  Green tea (Camellia sinensis) aqueous extract alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro.

Authors:  Xin Wu; Chuan-Qi Xie; Qiang-Qiang Zhu; Ming-Yue Wang; Bin Sun; Yan-Ping Huang; Chang Shen; Meng-Fei An; Yun-Li Zhao; Xuan-Jun Wang; Jun Sheng
Journal:  Food Nutr Res       Date:  2018-10-08       Impact factor: 3.894

10.  The effect of total flavonoids of Epimedium on granulosa cell development in laying hens.

Authors:  Yu Guo; Yurong Li; Shuang Zhang; Xianjun Wu; Luying Jiang; Qianhui Zhao; Wenhui Xue; Shuying Huo
Journal:  Poult Sci       Date:  2020-06-24       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.